Bruker Corporation reports results for the quarter ended September 30 - Earnings Summary
Bruker Corporation reported quarterly adjusted earnings of 56 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 45 cents. The mean expectation of twelve analysts for the quarter was for earnings of 42 cents per share. Wall Street expected results to range from 40 cents to 45 cents per share.
Revenue rose 1.6% to $874.00 million from a year ago; analysts expected $868.83 million.
Bruker Corporation's reported EPS for the quarter was a loss of 81 cents.
The company reported a quarterly loss of $122.8 million.
Bruker Corporation shares had fallen by 12.7% this quarter and gained 19.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.7% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Bruker Corporation is $62.00, about 8.9% above its last closing price of $56.50
This summary was machine generated from LSEG data November 4 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.42 | 0.56 | Beat |
Jun. 30 2026 | 0.38 | 0.49 | Beat |
Mar. 31 2026 | 0.23 | 0.31 | Beat |
Dec. 31 2025 | 0.65 | 0.59 | Missed |